Published in J Virol on October 01, 2006
Advances in the understanding of the pathogenesis and epidemiology of herpes zoster. J Clin Virol (2010) 1.96
Specific capture and whole-genome sequencing of viruses from clinical samples. PLoS One (2011) 1.78
A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J Gen Virol (2010) 1.49
Impact of varicella vaccine on varicella-zoster virus dynamics. Clin Microbiol Rev (2010) 1.47
Herpesvirus systematics. Vet Microbiol (2010) 1.43
Pangaea and the Out-of-Africa Model of Varicella-Zoster Virus Evolution and Phylogeography. J Virol (2012) 1.17
Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol (2007) 1.16
Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination. J Virol (2011) 1.16
Genotyping of clinical varicella-zoster virus isolates collected in China. J Clin Microbiol (2009) 1.05
A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One (2011) 1.01
Household size is critical to varicella-zoster virus transmission in the tropics despite lower viral infectivity. Epidemics (2010) 0.97
Lineages of varicella-zoster virus. J Gen Virol (2009) 0.96
Simultaneous cocirculation of both European varicella-zoster virus genotypes (E1 and E2) in Mexico city. J Clin Microbiol (2010) 0.96
Novel approach for genotyping varicella-zoster virus strains from Germany. J Clin Microbiol (2007) 0.95
Recombination of Globally Circulating Varicella-Zoster Virus. J Virol (2015) 0.94
Bioinformatics of varicella-zoster virus: single nucleotide polymorphisms define clades and attenuated vaccine genotypes. Infect Genet Evol (2012) 0.92
Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster. J Clin Microbiol (2012) 0.89
Evidence of widespread natural recombination among field isolates of equine herpesvirus 4 but not among field isolates of equine herpesvirus 1. J Gen Virol (2015) 0.86
Structure and sequence of the saimiriine herpesvirus 1 genome. Virology (2010) 0.85
Evolution of cocirculating varicella-zoster virus genotypes during a chickenpox outbreak in Guinea-Bissau. J Virol (2014) 0.82
Genetic analysis of clinical VZV isolates collected in China reveals a more homologous profile. Biomed Res Int (2013) 0.81
Coinfection with two closely related alphaherpesviruses results in a highly diversified recombination mosaic displaying negative genetic interference. J Virol (2009) 0.81
A regulatory domain spanning the repeat sequence RE1 from herpes simplex virus type 1 has cell specific differential functions in trigeminal neurons and fibroblasts. FEBS Lett (2009) 0.78
Molecular analysis of varicella-zoster virus strains circulating in Tanzania demonstrating the presence of genotype M1. J Clin Microbiol (2008) 0.77
Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet. Med Microbiol Immunol (2011) 0.77
Analysis of enzymatic digestion pattern of two open reading frames of Varciella-Zoster genome from Kuwaiti patients using the RFLP technique. Iran J Microbiol (2012) 0.75
Genotyping of clinical varicella-zoster virus isolates collected from Yunnan in Southwestern China. Biomed Rep (2015) 0.75
Genetic analysis of varicella-zoster virus in the aqueous humor in uveitis with severe hyphema. BMC Infect Dis (2017) 0.75
MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics (2003) 130.85
Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol (1999) 18.82
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
The complete DNA sequence of varicella-zoster virus. J Gen Virol (1986) 16.00
Bayesian inference of phylogeny and its impact on evolutionary biology. Science (2001) 11.15
Outbreak of varicella at a day-care center despite vaccination. N Engl J Med (2002) 4.19
Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol (1995) 2.84
Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J Infect Dis (1991) 2.36
Gene content phylogeny of herpesviruses. Proc Natl Acad Sci U S A (2000) 2.24
Geographical prevalence of two types of Epstein-Barr virus. Virology (1986) 2.05
Phylogenetic analysis of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J Virol (2002) 1.87
Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol (2004) 1.85
Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis (2002) 1.83
The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine (2003) 1.72
Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J Virol (2004) 1.51
Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates. J Infect Dis (2000) 1.40
Clinical reinfection with varicella-zoster virus. J Infect Dis (1984) 1.34
Individuals from North America, Australasia, and Africa are infected with four different genotypes of human herpesvirus 8. Virology (1999) 1.32
Distribution of varicella-zoster virus strains carrying a PstI-site-less mutation in Japan and DNA change responsible for the mutation. Jpn J Exp Med (1989) 1.28
Strain variation of R5 direct repeats in the right-hand portion of the long unique segment of varicella-zoster virus DNA. J Virol (1988) 1.25
High recombination rate in herpes simplex virus type 1 natural populations suggests significant co-infection. Infect Genet Evol (2004) 1.23
Recombination in tissue culture between varicella-zoster virus strains. J Med Virol (1988) 1.23
Fine mapping and sequencing of a variable segment in the inverted repeat region of varicella-zoster virus DNA. J Virol (1985) 1.21
Restriction fragment differences between the genomes of the Oka varicella vaccine virus and American wild-type varicella-zoster virus. J Med Virol (1989) 1.17
Application of long PCR method of identification of variations in nucleotide sequences among varicella-zoster virus isolates. J Clin Microbiol (1996) 1.13
Second varicella infections: are they more common than previously thought? Pediatrics (2002) 1.11
Younger age at vaccination may increase risk of varicella vaccine failure. J Infect Dis (2002) 1.11
Typing of varicella zoster virus by amplification of DNA polymorphisms. J Virol Methods (1996) 1.11
Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J (2005) 1.09
Definition and distribution analysis of glycoprotein B gene alleles of human herpesvirus 7. J Virol (1998) 1.05
A fifth human cytomegalovirus glycoprotein B genotype. Res Virol (1998) 1.03
Variation within the glycoprotein B gene of human cytomegalovirus is due to homologous recombination. J Gen Virol (1999) 1.02
Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster. J Clin Microbiol (2004) 1.02
Genomic characterization of two predominant genotypes of herpes simplex virus type 1. Arch Virol (1993) 1.02
The Epstein-Barr virus EBNA-2 gene in oral hairy leukoplakia: strain variation, genetic recombination, and transcriptional expression. J Virol (1994) 1.00
Novel intertypic recombinants of epstein-barr virus in the chinese population. J Virol (2000) 1.00
Varicella vaccine: genesis, efficacy, and attenuation. Virology (2001) 0.97
Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates. J Clin Microbiol (2002) 0.95
Polymerase chain reaction for diagnosis of varicella zoster virus central nervous system infections without skin manifestations. Scand J Infect Dis Suppl (1996) 0.94
Natural history of varicella zoster virus. Semin Dermatol (1992) 0.86
Evolution of herpes simplex virus type 1 under herpesviral evolutionary processes. Arch Virol (1999) 0.85
Populations of two eastern countries of Japan and Korea and with a related history share a predominant genotype of herpes simplex virus type 1. Arch Virol (1997) 0.85
A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol (2010) 3.52
Varicella zoster virus ischemic optic neuropathy and subclinical temporal artery involvement. Arch Neurol (2011) 2.82
Comparative genomics of Vibrio cholerae from Haiti, Asia, and Africa. Emerg Infect Dis (2011) 2.50
Seroprevalence and correlates of herpes simplex virus type 2 infection in five sexually transmitted-disease clinics. J Infect Dis (2002) 2.08
VZV ischemic optic neuropathy and subclinical temporal artery infection without rash. Neurology (2012) 1.97
Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J Virol (2004) 1.85
Incidence of herpes simplex virus type 2 infection in 5 sexually transmitted disease (STD) clinics and the effect of HIV/STD risk-reduction counseling. J Infect Dis (2004) 1.79
Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J Med Virol (2008) 1.71
DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J Infect Dis (2007) 1.71
Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J Infect Dis (2008) 1.70
Changes to anti-JCV antibody levels in a Swedish national MS cohort. J Neurol Neurosurg Psychiatry (2013) 1.63
LIR-1 expression on lymphocytes, and cytomegalovirus disease in lung-transplant recipients. Lancet (2003) 1.59
Review of cytomegalovirus shedding in bodily fluids and relevance to congenital cytomegalovirus infection. Rev Med Virol (2011) 1.57
Monkeypox or varicella? Lessons from a rash outbreak investigation in the Republic of the Congo. Am J Trop Med Hyg (2009) 1.54
Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant viruses. J Virol (2004) 1.51
A proposal for a common nomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry, 24-25 July 2008. J Gen Virol (2010) 1.49
Glycoconjugate glycans as viral receptors. Ann Med (2005) 1.48
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics (2006) 1.48
Cytomegalovirus seroconversion rates and risk factors: implications for congenital CMV. Rev Med Virol (2010) 1.46
High rate of varicella complications among Mexican-born adults in Alabama. Clin Infect Dis (2004) 1.41
Varicella zoster virus vasculopathy: a treatable form of rapidly progressive multi-infarct dementia after 2 years' duration. J Neurol Sci (2012) 1.39
Recurrent polymorphonuclear pleocytosis with increased red blood cells caused by varicella zoster virus infection of the central nervous system: Case report and review of the literature. J Neurol Sci (2010) 1.38
Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis (2010) 1.36
Chasing Jenner's vaccine: revisiting cowpox virus classification. PLoS One (2011) 1.33
National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity. Clin Vaccine Immunol (2011) 1.28
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis (2003) 1.27
Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis (2004) 1.26
Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J Clin Microbiol (2006) 1.23
Valganciclovir in patients with glioblastoma. N Engl J Med (2013) 1.21
Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol (2009) 1.19
Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis (2008) 1.18
Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J Infect Dis (2008) 1.17
Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol (2007) 1.16
An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients--Arkansas, 2006. Pediatr Infect Dis J (2009) 1.15
Varicella seroprevalence in the U.S.: data from the National Health and Nutrition Examination Survey, 1999-2004. Public Health Rep (2010) 1.14
Why is tick-borne encephalitis increasing? A review of the key factors causing the increasing incidence of human TBE in Sweden. Parasit Vectors (2012) 1.14
Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes. Virology (2008) 1.13
New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J Virol Methods (2006) 1.11
Incidence and clinical characteristics of herpes zoster among children in the varicella vaccine era, 2005-2009. J Infect Dis (2013) 1.10
Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infants. Pediatrics (2013) 1.10
Varicella-zoster virus reactivation is an important cause of acute peripheral facial paralysis in children. Pediatr Infect Dis J (2005) 1.09
Prevalence of antibodies against herpes simplex virus types 1 and 2 in children and young people in an urban region in Tanzania. J Clin Microbiol (2006) 1.08
Detection and typing of Herpes Simplex virus (HSV) in mucocutaneous samples by TaqMan PCR targeting a gB segment homologous for HSV types 1 and 2. J Clin Microbiol (2005) 1.08
Evaluation of laboratory methods for diagnosis of varicella. Clin Infect Dis (2010) 1.07
Human Tick-Borne Encephalitis and Characterization of Virus from Biting Tick. Emerg Infect Dis (2016) 1.07
Detection of bacterial DNA in painful degenerated spinal discs in patients without signs of clinical infection. Eur Spine J (2004) 1.07
Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman. J Neurovirol (2009) 1.07
The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res (2004) 1.05
Secondary transmission of varicella vaccine virus in a chronic care facility for children. J Pediatr (2006) 1.05
Enteric viruses in healthy children in Cameroon: viral load and genotyping of norovirus strains. J Med Virol (2011) 1.05
Chondroitin 4-O-sulfotransferase-1 regulates E disaccharide expression of chondroitin sulfate required for herpes simplex virus infectivity. J Biol Chem (2006) 1.05
Chondroitin sulfate characterized by the E-disaccharide unit is a potent inhibitor of herpes simplex virus infectivity and provides the virus binding sites on gro2C cells. J Biol Chem (2005) 1.04
A frameshift mutation in golden retriever dogs with progressive retinal atrophy endorses SLC4A3 as a candidate gene for human retinal degenerations. PLoS One (2011) 1.03
Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster. J Clin Microbiol (2004) 1.02
Varicella vaccine in the United States: a decade of prevention and the way forward. J Infect Dis (2008) 1.02
Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis (2003) 1.01
Proportion of herpes simplex virus (HSV) type 1 and type 2 among genital and extragenital HSV isolates. Acta Derm Venereol (2002) 1.01
A genome-wide comparative evolutionary analysis of herpes simplex virus type 1 and varicella zoster virus. PLoS One (2011) 1.01
Herpes zoster caused by vaccine-strain varicella zoster virus in an immunocompetent recipient of zoster vaccine. Clin Infect Dis (2014) 1.00
Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology (2004) 0.99
Laboratory diagnosis and characteristics of breakthrough varicella in children. J Infect Dis (2008) 0.98
Deep sequencing of viral genomes provides insight into the evolution and pathogenesis of varicella zoster virus and its vaccine in humans. Mol Biol Evol (2013) 0.98
Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine. J Infect Dis (2008) 0.97
Genetic recombination of tick-borne flaviviruses among wild-type strains. Virology (2013) 0.97
Varicella zoster virus DNA at inoculation sites and in saliva after Zostavax immunization. J Infect Dis (2011) 0.96
Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts. Clin Vaccine Immunol (2006) 0.95
Dichotomy of glycoprotein g gene in herpes simplex virus type 1 isolates. J Clin Microbiol (2002) 0.95
Draft genome sequences of Bordetella holmesii strains from blood (F627) and nasopharynx (H558). Genome Announc (2013) 0.94
GeneChip resequencing of the smallpox virus genome can identify novel strains: a biodefense application. J Clin Microbiol (2006) 0.94
Genotyping of clinical herpes simplex virus type 1 isolates by use of restriction enzymes. J Clin Microbiol (2006) 0.94
Recombination of Globally Circulating Varicella-Zoster Virus. J Virol (2015) 0.94
Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J Gen Virol (2002) 0.93
Challenges in confirming a varicella outbreak in the two-dose vaccine era. Vaccine (2012) 0.93
Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain. Virology (2010) 0.92
Molecular analysis of an oyster-related norovirus outbreak. J Clin Virol (2009) 0.92
Secreted portion of glycoprotein g of herpes simplex virus type 2 is a novel antigen for type-discriminating serology. J Clin Microbiol (2003) 0.92
Comparison of rectal swabs and faeces for real-time PCR detection of enteric agents in Rwandan children with gastroenteritis. BMC Infect Dis (2013) 0.92
Varicella outbreak epidemiology in an active surveillance site, 1995-2005. J Infect Dis (2008) 0.92
Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1. Virology (2002) 0.91
Challenges to implementing second-dose varicella vaccination during an outbreak in the absence of a routine 2-dose vaccination requirement--Maine, 2006. J Infect Dis (2008) 0.90
A proinflammatory peptide from herpes simplex virus type 2 glycoprotein G affects neutrophil, monocyte, and NK cell functions. J Immunol (2005) 0.90
Acute viral infections of the central nervous system in immunocompetent adults: diagnosis and management. Drugs (2013) 0.90
Shift of Enterovirus species among children in Cameroon--identification of a new enterovirus, EV-A119. J Clin Virol (2013) 0.90
Evaluation of anti-HSV-2 activity of gallic acid and pentyl gallate. Biol Pharm Bull (2008) 0.90
Viruses detected among sporadic cases of parotitis, United States, 2009-2011. J Infect Dis (2013) 0.89
Novel genetic variation identified at fixed loci in ORF62 of the Oka varicella vaccine and in a case of vaccine-associated herpes zoster. J Clin Microbiol (2012) 0.89